4//SEC Filing
Murray Mark J. 4
Accession 0001123292-18-001091
CIK 0001447028other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 4:55 PM ET
Size
7.1 KB
Accession
0001123292-18-001091
Insider Transaction Report
Form 4
Murray Mark J.
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Shares
2018-11-28$1.35/sh+25,000$33,750→ 341,396 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-11-28−25,000→ 0 totalExercise: $1.35Exp: 2018-12-08→ Common Shares (25,000 underlying)
Footnotes (2)
- [F1]Converted from an exercise price of C$1.80 based on a conversion rate of C$1.33:$1.00 as of November 28, 2018.
- [F2]The option vested 1/4 on December 8, 2008, with the remaining portion vesting in equal annual installments beginning on December 8, 2009.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001628383
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 4:55 PM ET
- Size
- 7.1 KB